Prioritizing pregnant women for COVID‐19 vaccination
- 18 July 2021
- journal article
- review article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 155 (1) , 57-63
Abstract
Despite emerging evidence on safety and efficacy, most countries do not offer COVID‐19 vaccines to pregnant women even though they are at higher risk of complications from COVID‐19. We performed a web search of COVID‐19 vaccination policies for pregnant women under two categories: countries bearing a high burden of COVID‐19 cases and countries with a high burden of maternal and under‐five mortality. Of the top 20 countries affected by COVID‐19, 11 allow vaccination of pregnant women, of which two have deemed it safe to vaccinate pregnant women as a high‐risk group. In contrast, only five of the 20 countries with high under‐five mortality and maternal mortality allow vaccination of pregnant women and none of these countries has included them as part of a high‐risk group that should be vaccinated. India and Indonesia, with one‐fifth of the world's population, fall under both categories but do not include pregnant women as a priority group for COVID‐19 vaccination. To prevent COVID‐19 from further aggravating the already heavy burden of maternal and under‐five mortality, there is a strong case for including pregnant women as a high‐priority group for COVID‐19 vaccination. We recommend including COVID‐19 vaccination in routine antenatal care in all countries, particularly India and Indonesia in view of their high dual burden.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- COVID‐19 and acute coagulopathy in pregnancyJournal of Thrombosis and Haemostasis, 2022
- Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort studyAmerican Journal of Obstetrics and Gynecology, 2021
- Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington StateAmerican Journal of Obstetrics and Gynecology, 2021
- Covid-19: Brazil’s spiralling crisis is increasingly affecting young peopleBMJ, 2021
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccineNature Medicine, 2021
- Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccinationmedRxiv, 2021
- Effects of COVID-19 on maternal institutional delivery: Fear of a rise in maternal mortalityJournal of Global Health, 2021
- Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020MMWR. Morbidity and Mortality Weekly Report, 2020